• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Life Science Market
Life Science News
Life Science Stocks
  • Life Science Market
  • Life Science News
  • Life Science Stocks

Pharmaceutical Sales Anticipated to Reach $1.3 Trillion in 2018

Written by Morag Mcgreevey
|
Aug. 05, 2015 01:58PM PST

A new report anticipates that global pharmaceutical sales will reach $1.3 trillion by 2018.

A new report anticipates that global pharmaceutical sales will reach $1.3 trillion by 2018.
According to an article on PharmaTimes:

Worldwide sales passed the $1 trillion mark for the first time in 2014, and the 2015 CMR Pharmaceutical R&D Factbook from Thomson Reuters predicts that this increase will continue coupled with a rise in R&D productivity.
The authors note that 2014 saw the highest number of first-world new molecular entity (NME) launches in over a decade, with 46 such drugs entering the market. They say that this goes against perceptions that the industry is in a “era of scarcity”.
One third of these drugs were for rare indications, and more than 65% were speciality drugs for the treatment of cancer, hepatitis C and HIV.

Click here to read the full article on PharmaTimes.

thomson reuters
The Conversation (0)

Go Deeper

AI Powered
Blank pill bottle spilling a variety of pharmaceutical pills and capsules.

5 Biggest Pharmaceutical ETFs for Investors in 2026

Microscopic view of stem cells.

Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

Latest News

BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT

Government approvals secured for the use of Galidesivir as a treatment for Bundibugyo Ebola epidemic in Africa

Lexaria Updates Business Development

Lexaria Updates Business Development

More News

Outlook Reports world

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
  • Energy
    • Uranium
    • Oil and Gas
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Industrial Metals
  • Agriculture
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Gaming
    • Cleantech
    • Emerging Tech
Life Science
    • Biotech
    • Cannabis
    • Psychedelics
    • Pharmaceuticals

Featured Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES